Invivyd

Aerium Therapeutics

This biopharmaceutical company develops monoclonal antibodies and antiviral treatments to protect immunocompromised patients against COVID-19 and future epidemic threats.

Adagio Therapeutics

This biopharmaceutical company develops monoclonal antibody therapies for the prevention and treatment of viral respiratory diseases, primarily serving immunocompromised patients.

Adagio tx

This biopharmaceutical company develops monoclonal antibody treatments and prophylactics for infectious viral diseases to protect patients against coronaviruses and their evolving variants.

Arsanis

This biotechnology company develops monoclonal antibodies to treat and prevent serious infectious diseases for patients with life-threatening bacterial and viral infections.

Enanta

This biotechnology company develops small molecule medicines to treat viral infections and immunological diseases for patients with serious medical conditions.

RQ Bio

RQ Bio develops long-acting monoclonal antibodies to provide seasonal influenza protection for vulnerable and immunocompromised patients who cannot rely on vaccination alone.

CoVBio

The company develops broad-spectrum vaccines and therapeutic antibodies to protect the global population against coronaviruses and other respiratory viral infections.

Viridiantherapeutics

This company develops antibody treatments for patients living with rare autoimmune conditions and thyroid eye disease.